Death during intensive glycemic therapy of diabetes: mechanisms and implications
- PMID: 22017775
- PMCID: PMC3464092
- DOI: 10.1016/j.amjmed.2011.08.008
Death during intensive glycemic therapy of diabetes: mechanisms and implications
Figures
Comment on
-
Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities.Am J Med. 2011 Nov;124(11):1028-35. doi: 10.1016/j.amjmed.2011.07.011. Am J Med. 2011. PMID: 22017781 Free PMC article.
References
-
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–853. - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet. 1998;352:854–865. - PubMed
-
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
